KBC Group NV Has $26.64 Million Stake in Ventas, Inc. $VTR

KBC Group NV increased its holdings in shares of Ventas, Inc. (NYSE:VTR) by 3.8% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 325,800 shares of the real estate investment trust’s stock after purchasing an additional 11,780 shares during the period. KBC Group NV’s holdings in Ventas were worth $26,644,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Wiser Advisor Group LLC bought a new position in shares of Ventas in the 3rd quarter worth $27,000. IFC & Insurance Marketing Inc. bought a new stake in Ventas in the fourth quarter valued at approximately $30,000. Elyxium Wealth LLC acquired a new position in Ventas in the fourth quarter valued at about $33,000. Reflection Asset Management bought a new position in shares of Ventas during the 4th quarter valued at about $34,000. Finally, Manchester Capital Management LLC grew its position in shares of Ventas by 60.5% in the 4th quarter. Manchester Capital Management LLC now owns 491 shares of the real estate investment trust’s stock valued at $38,000 after purchasing an additional 185 shares during the period. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Price Performance

NYSE VTR opened at $97.55 on Wednesday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 12 month low of $65.15 and a 12 month high of $97.64. The stock has a market cap of $47.43 billion, a price-to-earnings ratio of 177.37, a PEG ratio of 2.07 and a beta of 0.70. The company’s 50 day moving average is $87.62 and its two-hundred day moving average is $84.45.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company’s quarterly revenue was up 22.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, research analysts anticipate that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.1%. The ex-dividend date was Tuesday, June 30th. Ventas’s dividend payout ratio is currently 378.18%.

Insider Buying and Selling

In related news, Director Michael J. Embler bought 2,500 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The shares were acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

VTR has been the topic of a number of recent research reports. UBS Group raised their price target on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Citigroup upped their price objective on shares of Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Royal Bank Of Canada upped their price target on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. Mizuho set a $98.00 price objective on shares of Ventas in a research report on Friday, May 22nd. Finally, KeyCorp upped their target price on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $96.17.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.